Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Is This Vaccine Stock a Buy After Big News?
10:45am, Friday, 22'nd Jul 2022 The Motley Fool
Two years after the onset of COVID-19 in the U.S., a new vaccine is coming to market -- who will it help?
After Slashing Costs, Is Inovio a Buy?
10:30am, Friday, 22'nd Jul 2022 The Motley Fool
It's betting on success as a vaccine latecomer.
25 million children at risk of getting dangerous but preventable illnesses amid steep backslide in vaccinations
04:45pm, Saturday, 16'th Jul 2022 MarketWatch
The coronavirus pandemic has caused the biggest backslide in childhood vaccinations in about 30 years, putting some 25 million children at risk of contracting a dangerous but preventable disease, the
Here's How To Trade This Pattern On BlackBerry, Moderna And Palantir Stocks
03:28pm, Friday, 15'th Jul 2022 Benzinga
BlackBerry Ltd (NYSE: BB), Moderna Inc (NASDAQ: MRNA) and Palantir Technologies Inc (NYSE: PLTR) have been showing strength in comparison to the general market recently and are all trading in uptren
Novavax (NVAX) Down as EU Adds Side Effects to COVID Jab Label
12:28pm, Friday, 15'th Jul 2022 Zacks Investment Research
The administration of Novavax's (NVAX) COVID-19 vaccine leads to some cases of severe allergic reactions as well as skin problems, per a safety update issued by the EMA.
Novavax's protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low
10:27am, Friday, 15'th Jul 2022 MarketWatch
U.S. health regulators authorized the use of Novavax Inc.'s COVID-19 vaccine, providing a new option that works differently than the two leading vaccines based on mRNA technology, but the move comes
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
09:20am, Friday, 15'th Jul 2022 Benzinga
Gainers
Clene Inc. (NASDAQ: CLNN) shares jumped 43.4% to close at $4.13. Clene reported significantly improved survival in Amyotrophic lateral sclerosis (ALS) patients initially treated with CNM-Au8
Why Moderna Stock Is Sliding Today
08:02pm, Thursday, 14'th Jul 2022 The Motley Fool
Novavax stole its thunder by getting a critical thumbs-up from regulators.
Novavax's (NVAX) Protein-Based COVID Jab Gets EUA in the US
03:06pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Following the grant of emergency use authorization by the FDA, Novavax's (NVAX) COVID-19 vaccine is the first protein-based COVID vaccine authorized for use in the United States.
Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study
02:59pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
Moderna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine, targeting the Nipah virus. It also starts a mid-stage study evaluating its Zika virus vaccine.
Why Novavax Stock Shot Higher Today
09:20pm, Tuesday, 12'th Jul 2022 The Motley Fool
A media report says that the company's coronavirus vaccine is about to be authorized for use in the U.S.
Novavax (NVAX) Inks COVID Jab Supply Deal With US Government
07:31pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Novavax (NVAX) inks a deal with the US government to supply 3.2 million doses of COVID shot. But the deal will be effective only if the vaccine gets EUA from the FDA. It also needs CDC recommendation.
Moderna (MRNA) Bivalent COVID Booster Effective Against BA.4/5
07:16pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Moderna's (MRNA) bivalent COVID booster candidate exhibits a higher antibody response against all-tested COVID-19 variants, including the Omicron subvariants BA.4 and BA.5.
1 Green Flag and 1 Red Flag for Moderna
02:37pm, Tuesday, 12'th Jul 2022 The Motley Fool
There are two sides to each argument, but which side is stronger?
Novavax Stock: Bear vs. Bull
10:00am, Tuesday, 12'th Jul 2022 The Motley Fool
Can this vaccine latecomer win market share?
